Sex: M
Vaccine: DTPPVHBHPB, FLU4
Symptoms: Circumstance or information capable of leading to medication error, No adverse event, Product use issue, Wrong product administered
Clinical narrative: Patient inadvertently received a dose of Vaxelis, instead of the ordered Fluzone High Dose QIV; product use in unapproved population; No Adverse Event; This non-serious case was received during the monitoring on 12-JAN-2023. The original narrative from the sender is the following:  Patient inadvertently received a dose of VAXELIS, nurse accidentally pulled and administered VAXELIS, instead of the ordered FLUZONE HIGH DOSE QIV, with no reported adverse event; Initial information received on 08-Nov-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 73-year-old male patient who inadvertently received a dose of DIPHTHERIA, TETANUS, AC PERTUSSIS, HEP B, IPV AND HIB VACCINE (Vaxelis), nurse accidentally pulled and administered vaxelis, instead of the ordered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (strength, formulation, dose, route: unknown) (lot number and expiry date: not reported) in unknown administration site for Immunization and suspect DIPHTHERIA, TETANUS, AC PERTUSSIS, HEP B, IPV AND HIB VACCINE produced by unknown manufacturer (strength, formulation, dose, route: unknown) (lot number and expiry date: not reported) in unknown administration site for Prophylactic vaccination (Immunisation) and patient inadvertently received a dose of vaxelis, nurse accidentally pulled and administered vaxelis, instead of the ordered fluzone high dose qiv, with no reported adverse event (wrong product administered) (unknown latency). It was reported, ordering physicians ordered FLUZONE HIGH DOSE QIV for both patients. This situation is reported as a medication error due to a missed dose of FLUZONE HIGH DOSE QIV. As patient did not receive dose of ordered FLUZONE HIGH DOSE QIV on 07NOV2022. No further information provided by the reporter. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) and DIPHTHERIA, TETANUS, AC PERTUSSIS, HEP B, IPV AND HIB VACCINE (DIPHTHERIA, TETANUS, AC PERTUSSIS, HEP B, IPV AND HIB VACCINE) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Patient inadvertently received a dose of Vaxelis, instead of the ordered Fluzone High Dose QIV", "No adverse event" and "product use in unapproved population".  No further information is expected.